Table 1 Expression of Tribbles increased... | American Society of Hematology

Table 1

Expression of Tribbles increased in specific AML karyotypes and FAB subtypes

Studies	Trib1 (202241_at)		Trib2 (202478_at)		Trib3 (218145_at)
Studies	Karyotype	FAB	Karyotype	FAB	Karyotype	FAB
Valk et al⁹*	inv(16) or t(16; 16)†	M4†	NS	NS	t(8;21)†	M2†
Valk et al⁹*	inv(16) or t(16; 16)†	M5‡	NS	NS	t(15;17)†	M3‡
Gutierrez et al¹⁰	inv(16) (p12; q13)†	M4Eo†	NS	NS	t(15;17)(q12;q21)†	M3†
Verhaak et al¹¹	idt(16)†	M4‡	NS	RAEB†	t(6;9)†	M2‡
	inv(16)‡	M5‡		RAEB-t†	t(8;21)‡	M3‡
	t(6;9)†	M5‡		RAEB-t†	t(15;17)‡	M3‡
Haferlach et al¹²*	complex†	—	complex†	—	complex‡	—
Haferlach et al¹²*	t(8;21)†	—	inv(16) or t(16;16)†	—	t(15;17)†	—
Eppert et al¹³	+13†	NS	inv(16)(p13;q22)†	M4Eo†	NS	NS
Eppert et al¹³	inv(16)(p13;q22)†	NS	inv(16)(p13;q22)†	M4Eo†	NS	NS

Studies	Trib1 (202241_at)		Trib2 (202478_at)		Trib3 (218145_at)
Studies	Karyotype	FAB	Karyotype	FAB	Karyotype	FAB
Valk et al⁹*	inv(16) or t(16; 16)†	M4†	NS	NS	t(8;21)†	M2†
Valk et al⁹*	inv(16) or t(16; 16)†	M5‡	NS	NS	t(15;17)†	M3‡
Gutierrez et al¹⁰	inv(16) (p12; q13)†	M4Eo†	NS	NS	t(15;17)(q12;q21)†	M3†
Verhaak et al¹¹	idt(16)†	M4‡	NS	RAEB†	t(6;9)†	M2‡
	inv(16)‡	M5‡		RAEB-t†	t(8;21)‡	M3‡
	t(6;9)†	M5‡		RAEB-t†	t(15;17)‡	M3‡
Haferlach et al¹²*	complex†	—	complex†	—	complex‡	—
Haferlach et al¹²*	t(8;21)†	—	inv(16) or t(16;16)†	—	t(15;17)†	—
Eppert et al¹³	+13†	NS	inv(16)(p13;q22)†	M4Eo†	NS	NS
Eppert et al¹³	inv(16)(p13;q22)†	NS	inv(16)(p13;q22)†	M4Eo†	NS	NS

AML samples with unknown karyotype or FAB subtype were excluded from statistical analysis provided by the LGA.

NS, no statistically significant increased expression found; –,unavailable data for statistical analysis.

AML samples with normal karyotype were not able to be included in the statistical analysis.

Statistically significant increased expression with adjusted P < .05 in Welch’s t test.

Statistically highly significant increased expression with adjusted P < .001 in Welch’s t test.